Kashif Rashid Net Worth

The estimated Net Worth of Kashif Rashid is at least $1.16 Milione dollars as of 9 May 2022. Mr. Rashid owns over 2,250 units of Nevro Corp stock worth over $252,107 and over the last 7 years he sold NVRO stock worth over $0. In addition, he makes $905,912 as Chief Compliance Officer, General Counsel e Corporate Secretary at Nevro Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Rashid NVRO stock SEC Form 4 insiders trading

Kashif has made over 3 trades of the Nevro Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 2,250 units of NVRO stock worth $100,125 on 9 May 2022.

The largest trade he's ever made was buying 2,250 units of Nevro Corp stock on 9 May 2022 worth over $100,125. On average, Kashif trades about 140 units every 4 days since 2017. As of 9 May 2022 he still owns at least 53,526 units of Nevro Corp stock.

You can see the complete history of Mr. Rashid stock trades at the bottom of the page.

Kashif Rashid biography

Kashif Rashid J.D. serves as Chief Compliance Officer, General Counsel, Corporate Secretary of the Company. From March 2017 to December 2017, Mr. Rashid served as Vice President, Legal at Atara Biotherapeutics, Inc., a biotechnology company focused on T-cell immunotherapy. From June 2008 to February 2017, Mr. Rashid served first as Associate General Counsel and later as Deputy General Counsel at St. Jude Medical, Inc., a medical device company. From September 1998 to June 2008, Mr. Rashid served in roles of increasing responsibility at General Electric Company's Healthcare business, Loews Corporation and Kaye Scholer, LLP, a global law firm. Mr. Rashid received a B.S. in Business Administration from the George Washington University and a J.D. from Georgetown University Law Center.

What is the salary of Kashif Rashid?

As the Chief Compliance Officer, General Counsel e Corporate Secretary of Nevro Corp, the total compensation of Kashif Rashid at Nevro Corp is $905,912. There are 6 executives at Nevro Corp getting paid more, with D.Keith Grossman having the highest compensation of $13,877,700.

How old is Kashif Rashid?

Kashif Rashid is 46, he's been the Chief Compliance Officer, General Counsel e Corporate Secretary of Nevro Corp since 2017. There are 24 older and no younger executives at Nevro Corp. The oldest executive at Nevro Corp is Frank Fischer, 78, who is the Independent Director.

What's Kashif Rashid's mailing address?

Kashif's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.

Insiders trading at Nevro Corp

Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo e & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.

What does Nevro Corp do?

headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.

Complete history of Mr. Rashid stock trades at Nevro Corp

Nevro Corp executives and stock owners

Nevro Corp executives and other stock owners filed with the SEC include:

• D.Keith Grossman,
  Chairman of the Board, President, Chief Executive Officer
• Niamh Pellegrini,
  Chief Commercial Officer
• Michael Carter,
  Vice President - Global Sales
• Christopher Christoforou,
  Vice President - Research and Development
• D. Keith Grossman,
  Chairman, CEO & Pres
• Patrick Schmitz,
  Vice President - Operations
• Kashif Rashid,
  Chief Compliance Officer, General Counsel, Corporate Secretary
• Andrew H. Galligan,
  Exec. Officer
• Kashif Rashid,
  Gen. Counsel, Corp. Sec. & Chief Compliance Officer
• Roderick H. MacLeod,
  Chief Financial Officer
• Elizabeth Weatherman,
  Independent Director
• Kevin O'Boyle,
  Independent Director
• Karen Prange,
  Independent Director
• Michael DeMane,
  Lead Independent Director
• Wilfred Jaeger,
  Independent Director
• Shawn McCormick,
  Independent Director
• Frank Fischer,
  Independent Director
• Brad Vale,
  Independent Director
• David Caraway,
  Chief Medical Officer
• Donald Middlebrook,
  Vice President - Clinical, Regulatory and Quality
• Juliet Cunningham,
  Vice President - Investor Relations
• Lori Ciano,
  Chief Human Resource Officer
• Roderick MacLeod,
  Chief Financial Officer
• Dr. David Caraway,
  Chief Medical Officer
• Lori M. Ciano,
  Chief HR Officer
• Patrick Schmitz,
  VP of Operations
• Jon R. Shear,
  VP of Corp. Devel.
• Michael Collier Carter,
  VP of Global Sales
• Julie D. Dewey,
  Chief Corp. Communications & Investor Relations Officer
• Sridhar Kosaraju,
  
• James Alecxih,
  Vice President, Sales
• Lisa D Earnhardt,
  Director
• Andre Walker,
  Senior VP,Research&Development
• Ali Behbahani,
  Director
• Kevin R Thornal,
  President & CEO
• Rami Elghandour,
  President
• Michael Enxing,
  VP of Sales & Marketing
• Arch Management Iv, L.L.C.T...,
  
• City Capital Llc Bay City C...,
  
• Holdings A/S Novo,
  10% owner
• Partners Ii Lp Amv,
  
• City Capital Llc Bay City C...,
  
• Nathan B Pliam,
  Director
• & Johnson Johnson & Johnson...,
  
• Balakrishnan Shankar,
  VP, Operations
• Andrew H Galligan,
  Chief Financial Officer
• Doug Alleavitch,
  VP, Quality
• Kirt P Karros,
  
• Christofer Christoforou,
  SVP, Chief Operating Officer
• Greg Siller,
  SVP & Chief Commercial Officer
• Richard B. Carter,
  Chief Accounting Officer
• Susan E Siegel,